Latest News
Also, Wellumio has received $4 million in pre-Series A funding to further develop its portable, AI-augmented brain scanner.
Also, Omniscient Neurotechnology has received $14 million in government-backed funding to scale its AI-based brain mapping platform.
The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.
Screening rates in northern Queensland lag behind the statewide average.
The model can also make zero-shot predictions.
It demonstrated over 90% accuracy in detecting binary foetal movements in a hospital trial.
